Showing results (151-160 of 174) with videos related to
Sort By:
Pageof 18
International Journal of Antimicrobial Agents|April 9, 2013
A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failureAnne-Geneviève Marcelin, Constance Delaugerre, Céline Beaudoux, et al.Lancet (London, England)|June 15, 2020
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based studySilvia Stringhini, Ania Wisniak, Giovanni Piumatti, et al.Journal of Viral Hepatitis|May 13, 2020
Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infectionJulia Dietz, Olga V Kalinina, Johannes Vermehren, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2022
Similar But Different: Integrated Phylogenetic Analysis of Austrian and Swiss HIV-1 Sequences Reveal Differences in Transmission Patterns of the Local HIV-1 EpidemicsKatharina Kusejko, Nadine Tschumi, Sandra E Chaudron, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 2, 2020
Host Genomics of the HIV-1 Reservoir Size and Its Decay Rate During Suppressive Antiretroviral TreatmentChristian W Thorball, Alessandro Borghesi, Nadine Bachmann, et al.The Journal of Experimental Medicine|May 26, 2018
Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activityClaus Kadelka, Thomas Liechti, Hanna Ebner, et al.Nature Communications|July 21, 2019
Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ARTNadine Bachmann, Chantal von Siebenthal, Valentina Vongrad, et al.Lancet (London, England)|August 8, 2006
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trialJintanat Ananworanich, Angèle Gayet-Ageron, Michelle Le Braz, et al.The Journal of Antimicrobial Chemotherapy|October 27, 2014
Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasmaCathia Soulie, Diane Descamps, Maxime Grudé, et al.Nature Medicine|November 8, 2016
Determinants of HIV-1 broadly neutralizing antibody inductionPeter Rusert, Roger D Kouyos, Claus Kadelka, et al.Pageof 18